Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT02429362 |
Other study ID # |
14-03383-XP |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
May 2015 |
Est. completion date |
June 25, 2020 |
Study information
Verified date |
November 2020 |
Source |
University of Tennessee |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
Subjects are being asked to donate blood, urine, vaginal secretions and/or tissue to a
repository for research.This repository will store donated specimens for future research. The
Department of Obstetrics and Gynecology at the University of Tennessee Health Science Center,
under the direction of Dr. Giancarlo Mari, Professor and Chair, is responsible for the
operation of the repository.
Additionally, in the case of a stillborn child, the mother will be given the opportunity to
donate samples from her stillborn baby's autopsy to a repository for research.
Description:
The stored samples will be used in studies to help researchers understand normal events in
pregnancy, as well as events that occur when women and/or their babies have a disease or
condition during pregnancy. Additionally, the samples may be used in future studies to
develop cell lines for research, create tests to diagnose disease, or develop treatments. A
cell line is the result of cells grown outside the body in a laboratory. This process will
allow those cells to grow continuously when given the appropriate nutrients and conditions
for growth, and will result in a permanent cell culture which is the collection of cells that
are grown outside the body in a laboratory.
The stored samples will also be used in future studies to help researchers identify genetic
influences during pregnancy. Genes are like blueprints in each of your cells that determine
traits that you inherit, like eye color and hair color. Genes may also influence what
diseases you get and how you respond to treatment. DNA is the substance that makes up your
genes.
The subject will sign an informed consent for her participation (Primary Informed Consent).
In the situation of a stillbirth occurring, the mother of the stillborn baby will sign an
informed consent regarding the tissue samples to be obtained during the hospital's routinely
performed autopsy. (Secondary Informed Consent).